ATE90354T1 - Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden. - Google Patents
Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden.Info
- Publication number
- ATE90354T1 ATE90354T1 AT88903410T AT88903410T ATE90354T1 AT E90354 T1 ATE90354 T1 AT E90354T1 AT 88903410 T AT88903410 T AT 88903410T AT 88903410 T AT88903410 T AT 88903410T AT E90354 T1 ATE90354 T1 AT E90354T1
- Authority
- AT
- Austria
- Prior art keywords
- polydeoxyribonucleotides
- production
- pharmaceutical compositions
- novel compounds
- dna
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000005549 deoxyribonucleoside Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- -1 poly(deoxyribonucleotides) Polymers 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8700724A NL8700724A (nl) | 1987-03-27 | 1987-03-27 | Poly(deoxyribonucleotiden), farmaceutische samenstellingen, gebruik en bereiding van de poly(deoxyribonucleotiden). |
| EP88903410A EP0358657B1 (de) | 1987-03-27 | 1988-03-25 | Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden |
| PCT/NL1988/000013 WO1988007542A1 (en) | 1987-03-27 | 1988-03-25 | Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE90354T1 true ATE90354T1 (de) | 1993-06-15 |
Family
ID=19849775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88903410T ATE90354T1 (de) | 1987-03-27 | 1988-03-25 | Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0358657B1 (de) |
| JP (1) | JPH02503911A (de) |
| AT (1) | ATE90354T1 (de) |
| DE (1) | DE3881691T2 (de) |
| NL (1) | NL8700724A (de) |
| WO (1) | WO1988007542A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07501314A (ja) * | 1991-05-10 | 1995-02-09 | ハイブライドン インコーポレイテッド | ３′−末端封鎖されたオリゴヌクレオチド |
| US5502177A (en) | 1993-09-17 | 1996-03-26 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
| US5750674A (en) * | 1995-05-23 | 1998-05-12 | Hybridon, Inc. | Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced |
| AU5871196A (en) * | 1995-05-23 | 1996-12-24 | Hybridon, Inc. | Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced |
| WO1996039414A1 (en) * | 1995-06-01 | 1996-12-12 | Hybridon, Inc. | Novel base protecting groups for oligonucleotide synthesis |
| US6531589B1 (en) | 1995-06-01 | 2003-03-11 | Hybridon, Inc. | Base protecting groups and synthons for oligonucleotide synthesis |
| US5962674A (en) * | 1995-06-01 | 1999-10-05 | Hybridon, Inc. | Synthesis of oligonucleotides containing alkylphosphonate internucleoside linkages |
| WO1998033806A1 (en) * | 1997-02-04 | 1998-08-06 | Hybridon, Inc. | Base protecting groups and process for oligonucleotide synthesis |
| US9481905B2 (en) * | 2013-02-19 | 2016-11-01 | Orizhan Bioscience Limited | Method of using neutrilized DNA (N-DNA) as surface probe for high throughput detection platform |
| WO2015168461A2 (en) * | 2014-04-30 | 2015-11-05 | Agilent Technologies, Inc. | Phosphorous protecting groups and methods of preparation and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0090789A1 (de) * | 1982-03-26 | 1983-10-05 | Monsanto Company | Chemische DNA-Synthese |
| EP0108387B1 (de) * | 1982-11-04 | 1990-05-16 | F. Hoffmann-La Roche Ag | Hestellung von rekombinanten wachstumsauslösenden Faktoren |
-
1987
- 1987-03-27 NL NL8700724A patent/NL8700724A/nl not_active Application Discontinuation
-
1988
- 1988-03-25 JP JP63503102A patent/JPH02503911A/ja active Pending
- 1988-03-25 EP EP88903410A patent/EP0358657B1/de not_active Expired - Lifetime
- 1988-03-25 AT AT88903410T patent/ATE90354T1/de not_active IP Right Cessation
- 1988-03-25 DE DE88903410T patent/DE3881691T2/de not_active Expired - Fee Related
- 1988-03-25 WO PCT/NL1988/000013 patent/WO1988007542A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NL8700724A (nl) | 1988-10-17 |
| EP0358657A1 (de) | 1990-03-21 |
| DE3881691T2 (de) | 1993-09-30 |
| EP0358657B1 (de) | 1993-06-09 |
| DE3881691D1 (de) | 1993-07-15 |
| JPH02503911A (ja) | 1990-11-15 |
| WO1988007542A1 (en) | 1988-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK81093A (da) | Substituerede 3-aminopropanphosphonsyrlingforbindelser og salte deraf | |
| EE9800080A (et) | (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid | |
| BG45700A3 (bg) | Метод за получаване на алфа-хетероциклично заместени толунитрили | |
| DK320587D0 (da) | Nye farmakologiske forbindelser | |
| DZ615A1 (fr) | Composés nouveaux. | |
| FI961809A0 (fi) | Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit | |
| ATE90345T1 (de) | Bis-naphthalimide, ihre herstellung und verwendung. | |
| DE69941791D1 (de) | Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen | |
| DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
| BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
| IS1565B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
| BR9813651A (pt) | Compostos antipicornavirais e métodos para o seu uso e preparação | |
| ATE86858T1 (de) | Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst. | |
| DE59409094D1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
| ATE90354T1 (de) | Polydeoxyribonukleotide, pharmazeutische zusammensetzungen, verwendung und herstellung von polydeoxyribonukleotiden. | |
| ATE316964T1 (de) | Substituierte 4-amino-2-aryl-cyclopenta (d)pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| ES2088633T3 (es) | Estabilizantes polisiloxanicos que contienen grupos fenol y grupos oxamidicos estericamente impedidos. | |
| BR0110077A (pt) | Compostos e composições antipicornavirais, seus usos farmacêuticos, e materiais para a sua sìntese | |
| NO883074L (no) | Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater. | |
| SE8600658D0 (sv) | Novel composition of matter | |
| DE3686786D1 (de) | Menschliche proteine des chinolinesterase-typs und ihre herstellung. | |
| DE3784768D1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| BG104958A (bg) | Стабилни състави, съдържащи левосимендан и алгинова киселина | |
| ATE46687T1 (de) | Basisch substituierte phenylacetaldehyde, ihre herstellung und diese enthaltende arzneimittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |